Comparing Standard Platelet-Rich Plasma and Light-Enhanced Platelet-Rich Plasma for Treating Hair Loss in Androgenetic Alopecia: A Randomized Controlled Trial
Photobiomodulated Platelet-Rich Plasma for Androgenetic Alopecia: A Randomized Controlled Trial Comparing Standard PRP vs Red-Light Enhanced vs Blue-Light Enhanced PRP Using the MetaCell Technologies System
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Not yet recruiting
- Declared phase
- Early phase 1
- Sponsor
- Kimberly Meathrel
- Participants (registry)
- 30
- Start
- December 2026 (planned)
- Primary completion
- December 2027 (planned)
- Study completion
- December 2027 (planned)
- Last registry update
- July 2026
- Countries
- —
Conditions studied: Androgenetic Alopecia
Interventions: Platelet-Rich Plasma (PRP) Injections, Red-light photobiomodulation with cooling, Blue-light photobiomodulation
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.